What the research shows
Yoshino and colleagues conducted a ten-week, double-blind trial in postmenopausal women with prediabetes and overweight or obesity. They used a controlled insulin and glucose test to measure how effectively the body cleared glucose. Insulin-stimulated glucose disposal rose after NMN, with no corresponding change after placebo. Muscle samples also showed changes in insulin signaling. The trial did not measure lifespan or long-term diabetes prevention. Read the randomized NMN study.
Documented formats
The clinical study compared an NMN supplement with placebo. The beta form of NMN has its own chemical record, which is useful for matching a specification to the intended molecule.
Testing and purity
Look for beta-nicotinamide mononucleotide on the sample record. A result labeled only “NAD precursors” leaves open which molecule the laboratory actually quantified.
How to read a batch reportQuestions about NMN
What did the insulin and glucose test add?
By controlling insulin and keeping blood glucose steady, investigators could estimate how much glucose tissues took up under comparable conditions.
Who participated in the trial?
It enrolled postmenopausal women with prediabetes and overweight or obesity. The results apply most directly to that particular group and ten-week observation period.